FDA classifies devices according to the risk they pose to…
““FDA classifies devices according to the risk they pose to consumers. Premarket review is required for moderate- and high-risk devices. There are two paths that manufacturers can use to bring such devices to market. One path consists of conducting clinical studies, submitting a premarket approval (PMA) application and requires evidence providing reasonable assurance that the device is safe and effective. The other path involves submitting a 510(k) notification demonstrating that the device is substantially equivalent to a device already on the market (a predicate device) that does not require a PMA. The 510(k) process results in FDA clearance and tends to be much less expensive and less time-consuming than seeking FDA approval via PMA.””
About This Quote
This interpretation was drafted with AI assistance. It is one reading of the quote, not the author's own explanation.
FDA offers two regulatory pathways for medical devices: a rigorous premarket approval for high‑risk devices, and a faster 510(k) clearance for devices substantially equivalent to existing ones.
In simple terms: Two FDA routes: thorough approval for high‑risk, quicker clearance for similar devices.
Key Takeaway
Choose the pathway that matches device risk.
Themes
regulation
medical devices
risk assessment
approval processes
Mood
analytical
pragmatic
Type
drug:0
two paths:0
fda approval:1
premarket approval:1
fda classifies:0
premarket review:1
consumers premarket:0
When to use this quote
- product development
- clinical testing
- business planning
- legal review
- risk management
Key Concepts
health policy
industry compliance
market entry strategies
Questions to Reflect On
- Which pathway suits your device?
- What are the trade‑offs of each route?
A Different Perspective
High‑risk devices may face delays.